<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[diagnostics Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/diagnostics.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to diagnostics]]></description>
	<s:counts start="0" returned="20" found="93" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Sequenom, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-268095.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Harry Stylli While we are waiting for the first question I want to inform you that we are thinking about holding a commercial day event in the April timeframe, if there is sufficient interest from the investor community. The focus of this event would be...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Wed, 11 Feb 2009 19:21:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/analysis+tool.html"><![CDATA[Analysis Tool]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[Analysis]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[Diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/sequenom+inc..html"><![CDATA[Sequenom Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SQNM</category>
		<category domain="tickers">SQNM</category>
	</item>
	<item>
		<title><![CDATA[New Director Elected to California Healthcare Institute Board]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Oct_22/ai_n30917915]]></link>
		<description><![CDATA[LA JOLLA, Calif. -- The California Healthcare Institute CHI today announced that Michael A. Friedman, M.D., president and chief executive officer of City of Hope, a leading cancer research, treatment and education center, was elected to its board of directors. CHI is a non-profit public policy research organization, representing leading...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 22 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[board]]></category>
		<category domain="http://resources.bnet.com/topic/california.html"><![CDATA[California]]></category>
		<category domain="http://resources.bnet.com/topic/california+healthcare+institute.html"><![CDATA[CALIFORNIA HEALTHCARE INSTITUTE]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/friedman.html"><![CDATA[Friedman]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Growing Demand for Infectious Disease Diagnostics across East Africa]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_8/ai_n27892273]]></link>
		<description><![CDATA[CAPE TOWN, South Africa -- Infectious disease diagnostics markets across east Africa are expanding steadily. This is mainly due to the increasing number of patients on antiretrovirals ARVs and the scaling up of voluntary counselling and testing programmes in the region.  New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), East...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 08 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/africa.html"><![CDATA[Africa]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/malaria.html"><![CDATA[malaria]]></category>
		<category domain="http://resources.bnet.com/topic/procurement.html"><![CDATA[procurement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Western European In Vitro Diagnostics Market Sustained by New Technologies]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_1/ai_n27876323]]></link>
		<description><![CDATA[LONDON -- Despite issues such as rising R&D costs, poor reimbursement and a decline in prices, the emergence of new technologies is boosting the Western European in vitro diagnostics IVD markets. While the introduction of automation and integrated platforms has spurred mature segments such as clinical chemistry and immunoassay, new...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/automation.html"><![CDATA[automation]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[G&L Precision Die Cutting makes charitable contributions in celebration of its 30th anniversary]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6159/is_6_6/ai_n29454527]]></link>
		<description><![CDATA[[ILLUSTRATION OMITTED]  In 1978, Jerry and Loren Alberico, along with Connie Pierce, identified a need for hub rings for floppy disks in the computer industry and started a die-cutting business with two machines in a garage. The founders expanded their morn-and-pop business, G&L Precision Die Cutting, to providing global...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/american+diabetes+association.html"><![CDATA[American Diabetes Association]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
	</item>
	<item>
		<title><![CDATA[European Nucleic Acid-Based Amplification Reagents Markets for Clinical Applications]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_24/ai_n27505243]]></link>
		<description><![CDATA[DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/33e995/european_nucleic_a) has announced the addition of Frost & Sullivan's new report "European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications" to their offering.  Research Overview:  This Frost & Sullivan research service titled European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications provides...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 24 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/networking.html"><![CDATA[NETWORKING]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Gen-Probe Wages Bidding War For Diagnostics Crown]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/100087/gen-probe-wages-bidding-war-for-diagnostics-crown/]]></link>
		<description><![CDATA[Diagnostic tests traditionally haven't gotten a huge amount of respect within the drug industry. Until recently, at least, most diagnostics were low-margin, almost commodity products that couldn't command the high prices -- much less the repeat business -- that drugs themselves could.    That's started to change with...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 04 Jun 2008 13:26:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/salary.html"><![CDATA[Salary]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[Diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/gen-probe.html"><![CDATA[Gen-Probe]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
	</item>
	<item>
		<title><![CDATA[New Directors Elected to California Healthcare Institute Board]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_29/ai_n25361829]]></link>
		<description><![CDATA[LA JOLLA, Calif. -- The California Healthcare Institute CHI today announced that Daniel O'Day, president and chief executive officer at Roche Molecular Diagnostics RMD, located in Pleasanton, Calif., and Michael Onuscheck, president of the neuromodulation division of Boston Scientific Corporation located in Valencia, Calif., have been elected to its board...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/board.html"><![CDATA[board]]></category>
		<category domain="http://resources.bnet.com/topic/boston+scientific+corp..html"><![CDATA[Boston Scientific Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/california.html"><![CDATA[California]]></category>
		<category domain="http://resources.bnet.com/topic/california+healthcare+institute.html"><![CDATA[CALIFORNIA HEALTHCARE INSTITUTE]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BSX</category>
		<category domain="tickers">BSX</category>
	</item>
	<item>
		<title><![CDATA[East African Infectious Disease Diagnostics Markets to Double in Value]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_15/ai_n25153724]]></link>
		<description><![CDATA[CAPE TOWN, South Africa -- The Healthcare group at Frost & Sullivan (http://www.healthcare.frost.com/) is pleased to announce that it will be hosting its second quarter analyst briefing on East African Infectious Disease Diagnostics Markets on 23 April 2008 at 2pm BST / 3pm CAT.  East African governments are scaling...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 15 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Market for POC Molecular Tests Boosted by Discovery of New Disease Markers]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_14/ai_n25150761]]></link>
		<description><![CDATA[LONDON -- As developers of point of care POC molecular tests enhance their application scope to detect new disease markers, the POC molecular diagnostics market will present attractive opportunities. Market participants can enhance the utilization of POC molecular tests by improvising the existing tests and simultaneously focusing on R&D to...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/molecular+inc..html"><![CDATA[Molecular Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Critical Role of Haematology Testing in Enabling Accurate Disease Diagnosis to Sustain Growth of European Haematology Testing Market]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_19/ai_n21107253]]></link>
		<description><![CDATA[LONDON -- Haematology diagnostics remains popular as it comprises important tests that determine an individual's disease state. The laboratory remains the primary site of haematology tests in Europe due to confidence in established methods of diagnosis. However, rising awareness of its benefits is set to boost the uptake of point-of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 Nov 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/fax.html"><![CDATA[Fax]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[QIAplex Named One of the Year's Most Innovative Technologies]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200710/ai_n20531292]]></link>
		<description><![CDATA[Wall Street Journal recognizes QIAGEN's multiplexing technology which is the basis for next generation molecular testing solutions  VENLO, The  Netherlands,  October 1,  2007  - QIAGEN,  the worldwide leading provider of  sample and  assay technologies  for research in life sciences,  applied...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 01 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/wall+street+journal.html"><![CDATA[Wall Street Journal]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Helixis, Inc. Announces Corporate Launch]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_29/ai_n27358450]]></link>
		<description><![CDATA[Company Will Focus on Development of Accurate, Fast and Low-Cost Molecular Diagnostics Products  CARLSBAD, Calif. -- Helixis, Inc., an early-stage diagnostics company focused on the development of low-cost, fast and accurate molecular diagnostic products, today announced the formal launch of the company's operations. Helixis' $10M Series A funding has...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 29 Aug 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/california+institute+of+technology.html"><![CDATA[California Institute of Technology]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/professor.html"><![CDATA[professor]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Managing public debt; from diagnostics to reform implementation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0QLQ/is_2007_August/ai_n19451527]]></link>
		<description><![CDATA[Managing public debt; from diagnostics to reform implementation.  The World Bank  2007  120 pages  $15.00  Paperback  HJ8015  This is the first part of a two-part study reporting on the results of a 12-country pilot program, which was jointly initiated by the Word Bank's...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 01 Aug 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/imf.html"><![CDATA[IMF]]></category>
		<category domain="http://resources.bnet.com/topic/world+bank.html"><![CDATA[World Bank]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[QIAGEN Signs Agreement for the Acquisition of eGene]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_April_13/ai_n27201504]]></link>
		<description><![CDATA[Strategic Transaction Adds Capillary Sample Separation Technology  VENLO, The Netherlands -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt, Prime Standard:QIA), the world's leading provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics, today announced, that its subsidiary QIAGEN North American Holdings, Inc. has signed a...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 13 Apr 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[analysis]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/dna.html"><![CDATA[DNA]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[The U.S. Immunoassay Diagnostics Market Is Forecasted to Undergo Moderate Growth From 2007 to 2013]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_March_28/ai_n18769015]]></link>
		<description><![CDATA[DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c52898) has announced the addition of the Frost & Sullivan report: U.S. Immunoassay Diagnostics Markets to their offering.  The Frost & Sullivan research service entitled U.S. Immunoassay Diagnostics Markets provides a market overview with estimates and forecasts of revenues, and share analysis, along...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 28 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/restraint.html"><![CDATA[restraint]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[The U.S. Immunoassay Diagnostics Market is Forecasted to Undergo Moderate Growth from 2007 to 2013.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200703/ai_n20193397]]></link>
		<description><![CDATA[M2 PRESSWIRE-28 March 2007-Research and Markets: The U.S.  Immunoassay Diagnostics Market is Forecasted to Undergo Moderate Growth  from 2007 to 2013.C1994-2007 M2 COMMUNICATIONS LTD    RDATE:28032007    Dublin: Research and Markets  (http://www.researchandmarkets.com/reports/c52899) has announced the  addition of the Frost & Sullivan report:...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 28 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Growing Incidence of Diseases and International Monetary Funding Fuel the Uptake of IVD Tests.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200703/ai_n20196392]]></link>
		<description><![CDATA[M2 PRESSWIRE-27 March 2007-Research and Markets: Growing Incidence  of Diseases and International Monetary Funding Fuel the Uptake of IVD  TestsC1994-2007 M2 COMMUNICATIONS LTD    RDATE:28032007    Dublin: Research and Markets  (http://www.researchandmarkets.com/reports/c52828) has announced the  addition of the Frost & Sullivan report: IVD...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/frost+%2526+sullivan.html"><![CDATA[Frost & Sullivan]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[SOFTWARE]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Fayetteville Shale Gas Venture Progress Report from PrimeGen Energy Corporation (OTCBB: PGNE).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200703/ai_n19549034]]></link>
		<description><![CDATA[M2 PRESSWIRE-21 March 2007-SmallCapStockWatch.com: Fayetteville  Shale Gas Venture Progress Report from PrimeGen Energy Corporation  (OTCBB: PGNE)C1994-2007 M2 COMMUNICATIONS LTD    RDATE:21032007    Stocks To Watch: PrimeGen Energy Corporation(OTCBB: PGNE) , Alcar  Chemicals Group Inc. (PinkSheets: ACMG), TouchStone Software Corporation  (OTCBB: BTOD), Pioneer...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 21 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/desktops.html"><![CDATA[Desktops]]></category>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[HARDWARE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pc.html"><![CDATA[PC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Engine Electronics Revisited.(Department)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4912/is_200703/ai_n19236718]]></link>
		<description><![CDATA[Engine Electronics Revisited     By Dave Jensen     EPA may require emission-control diagnostics on diesel engines.     Engine, equipment and emission-control manufacturers will need to  keep their lines of communication open for the next several years as  regulators focus...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Mar 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/diagnostics.html"><![CDATA[diagnostics]]></category>
		<category domain="http://resources.bnet.com/topic/electronics.html"><![CDATA[electronics]]></category>
		<category domain="http://resources.bnet.com/topic/emission.html"><![CDATA[emission]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/quality.html"><![CDATA[Quality]]></category>
		<category domain="http://resources.bnet.com/topic/regulations.html"><![CDATA[Regulations]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+environmental+protection+agency.html"><![CDATA[U.S. Environmental Protection Agency]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
